Navigation Links
MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
Date:11/17/2010

GAITHERSBURG, Md., Nov. 17, 2010 /PRNewswire/ -- MedImmune announced the winners of its 5th Annual Research Abstract Competition highlighting the work of the next generation of scientific leaders performing research in areas of respiratory, inflammation and autoimmune (RIA) disease. Graduate students and postdoctoral fellows from around the world were invited to submit abstracts on RIA research as part of a competition sponsored by MedImmune, AstraZeneca's global biologics unit.

First prize of $2,000 was awarded to Jennifer Martinez, Ph.D., Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, for her research topic "The role of LC3- associated phagocytosis in the clearance of dead cells."

Martinez noted: "I am appreciative for the recognition and the opportunity to present my data.  It was also a great chance to learn about research in the field my colleagues are doing around the world."  

Second and third prizes of $1,000 and $500 were awarded respectively to Jeremy Di Domizio, Ph.D., Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, and Donald Simons, Ph.D., of The Wistar Institute, Philadelphia.

"We are impressed by the quality of research that is being conducted by young scientists," said Bahija Jallal, executive vice president of research and development at MedImmune. "This competition, which is one of the many activities MedImmune leads to engage emerging scientists in advancing health and science education, uncovered some extraordinary ideas that could help researchers further understand approaches in the RIA therapeutic area."

The competition was open to graduate students and postdoctoral fellows worldwide, with ten finalists selected to present their research to a panel of MedImmune experts at the company's headquarters in Gaithersburg.  Evaluation of abstracts were based on the following criteria: scientific rationale, descripti
'/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. MedImmune Focused on Revolutionizing Cancer Care
2. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
3. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
4. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
5. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
6. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
7. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
8. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
11. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... , , , Letters ... , DES PLAINES, Ill., Sept. 10 The American Brain Tumor ... and creative research ideas for solving the challenges of brain tumor diagnosis and ... scientific breakthroughs over the past decade resulting in better treatments and longer lives ...
... EMERYVILLE, Calif., Sept. 10 NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: ... clinical stage company developing novel anti-infective compounds for the treatment ... fungal infections, announced today the start of a Phase 2a ... , , NovaBay,s partner in ...
Cached Medicine Technology:American Brain Tumor Association Calls for Discovery Research 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 3NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 4
(Date:5/19/2013)... Daily Gossip reporters have subjected Joel Marion and Brett ... Fat to a close analysis with the intention to ... is a detailed explanation of the diet suggested by ... two nutritionists have discovered during their research that there is ... and expenditure of our body, that is, the leptin hormone. ...
(Date:5/19/2013)... Reporter , , SATURDAY, May 18 (HealthDay News) -- ... disease overcome the fatigue and decreased muscle strength ... new research. Extra vitamin D "was associated ... greater quality of life and the ability to ... a research dietitian and doctoral candidate at Trinity ...
(Date:5/19/2013)... May 19, 2013 People in Minnesota have ... Altman Fitness is offering its 28 Day Fat Loss Formula. ... from the comfort of their own home. The product sells ... More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , ... leave their houses now, but after using the 28 Day ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob Poulos ... with fat burning diet plans, training workouts, ... Furnace package, people will receive the Fat Burning Furnace ... The Fat Burning Furnace manual includes fat loss knowledge, ... mass. In addition, this book covers step-by-step instructions, techniques ...
Breaking Medicine News(10 mins):Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... HealthDay Reporter , MONDAY, Feb. 28 (HealthDay News) -- Instructions ... sometimes taking an average of seven pills a day, may ... many patients don,t realize that they can take several medications ... easy to grasp are sorely needed, the researchers added. ...
... the failure of enzymes to break down specific kinds of ... severe physical and neurological problems and sometimes early death. ... of the Journal of Biological Chemistry , researchers at ... by Jeffrey D. Esko, PhD, professor in the Department of ...
... Researchers at the Cummings School of Veterinary Medicine have received ... Syndrome (HUS), a potentially fatal outcome of E. coli ... children. HUS is caused by the forms of ... for about 100,000 annual cases of illness in the United ...
... WASHINGTON, February 28, 2011) Results from a study ... American Society of Hematology reveal a close relationship between ... arteries carrying blood from the heart to the lungsand ... (known as myeloid abnormalities). The study, which was ...
... , MONDAY, Feb. 28 (HealthDay News) -- A ... of depression are less likely than other heart attack patients ... analyzed data on 6,874 heart attack patients admitted to 96 ... March 2005. Of these patients, 680 had a history of ...
... Kansas State University chemistry professor has been selected as ... promising young scholar, particularly in the research areas of ... professor of chemistry, has received the two-year $50,000 award, ... early-career scientists and scholars as a way to recognize ...
Cached Medicine News:Health News:Confusion Over Drug Dosing Common for Seniors 2Health News:Confusion Over Drug Dosing Common for Seniors 3Health News:New marker found for Sanfilippo disease 2Health News:Tufts receives patent for antibody treatment against hemolytic uremic syndrome 2Health News:Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities 2Health News:Heart Patients With Depression Often Find ER Delays 2Health News:K-State chemist's work brings more national recognition as promising early-career scientist 2
... The OSOM Ultra Strep A Test is ... Technology (DLT)**. DLT uses antibody labeled color ... the test device. DLT allows greater sensitivity ... sacrificing specificity. In the test procedure, a ...
... The female Fertell test is an easy ... that measures ovarian reserve by means of determining ... an in-stream urine sample. The test is performed ... 3 of the menstrual cycle) and is similar ...
... The Cholestech GDX System delivers an unmatched ... the ideal solution for assessing and monitoring a ... product demo, click here ., ,The CLIA-waived ... delivers A1C results in less than 5 minutes. ...
... using patented, innovative technology, measures a complete ... only 5 minutes from a simple fingerstick. ... get immediate liver function results. The scope ... only advantage to healthcare providers. The physician, ...
Medicine Products: